Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Ovarian Cancer

Clinical Trial at: Minnesota Oncology - Coon Rapids

3000-03-005/ENGOT-OV44 : A RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERAPY WITH TSR-042 AND NIRAPARIB VERSUS STANDARD OF CARE PLATINUM-BASED THERAPY AS FIRST-LINE TREATMENT OF STAGE III OR IV NONMUCINOUS EPITHELIAL OVARIAN CANCER

  • Details

ClinicalTrials.gov ID: NCT03602859
Diagnosis Type: NA
USOR Number: 17218

  • Practice Details

11850 Blackfoot St NW, Suite 100
Coon Rapids, Minnesota 55433
571.97 mi. away
P: (763) 712-2100

More Details View Practice Page

Rectal Cancer

Clinical Trial at: Minnesota Oncology - Coon Rapids

A Phase 2 Study of INCMGA00012 in Participants With Squamous Carcinoma of the Anal Canal Who Have Progressed Following Platinum-Based Chemotherapy (POD1UM-202)

  • Details

ClinicalTrials.gov ID: NCT03597295
Diagnosis Type: NA
USOR Number: 18134

  • Practice Details

11850 Blackfoot St NW, Suite 100
Coon Rapids, Minnesota 55433
571.97 mi. away
P: (763) 712-2100

More Details View Practice Page

Peritoneal Cancer

Clinical Trial at: Minnesota Oncology - Coon Rapids

3000-03-005/ENGOT-OV44 : A RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERAPY WITH TSR-042 AND NIRAPARIB VERSUS STANDARD OF CARE PLATINUM-BASED THERAPY AS FIRST-LINE TREATMENT OF STAGE III OR IV NONMUCINOUS EPITHELIAL OVARIAN CANCER

  • Details

ClinicalTrials.gov ID: NCT03602859
Diagnosis Type: NA
USOR Number: 17218

  • Practice Details

11850 Blackfoot St NW, Suite 100
Coon Rapids, Minnesota 55433
571.97 mi. away
P: (763) 712-2100

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Coon Rapids

A Phase III, Double-Blinded, Multicenter, Randomized Study Evaluating The Efficacy and Safety of Neo-adjuvant Treatment with Atezolizumab or Placebo in Combination with Platinum-Based Chemotherapy in Patients with Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (GO40241)

  • Details

ClinicalTrials.gov ID: NCT03456063
Diagnosis Type: NA
USOR Number: 17140

  • Practice Details

11850 Blackfoot St NW, Suite 100
Coon Rapids, Minnesota 55433
571.97 mi. away
P: (763) 712-2100

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Coon Rapids

Brigatinib in Patients With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non–Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib (2002)

  • Details

ClinicalTrials.gov ID: NCT03535740
Diagnosis Type: NSCLC
USOR Number: 18076

  • Practice Details

11850 Blackfoot St NW, Suite 100
Coon Rapids, Minnesota 55433
571.97 mi. away
P: (763) 712-2100

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Coon Rapids

A Phase III, Double-Blinded, Multicenter, Randomized Study Evaluating The Efficacy and Safety of Neo-adjuvant Treatment with Atezolizumab or Placebo in Combination with Platinum-Based Chemotherapy in Patients with Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (GO40241)

  • Details

ClinicalTrials.gov ID: NCT03456063
Diagnosis Type: NSCLC
USOR Number: 17140

  • Practice Details

11850 Blackfoot St NW, Suite 100
Coon Rapids, Minnesota 55433
571.97 mi. away
P: (763) 712-2100

More Details View Practice Page

Myelofibrosis

Clinical Trial at: Minnesota Oncology - Coon Rapids

INCB 39110-209, An Open-Label Phase 2 Study of Itacitinib (INCB039110) in Combination With Low-Dose Ruxolitinib or Itacitinib Alone Following Ruxolitinib in Subjects With Myelofibrosis

  • Details

ClinicalTrials.gov ID: NCT03144687
Diagnosis Type: NA
USOR Number: 17085

  • Practice Details

11850 Blackfoot St NW, Suite 100
Coon Rapids, Minnesota 55433
571.97 mi. away
P: (763) 712-2100

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Coon Rapids

A Parallel Phase 2 Study of Glesatinib, Sitravatinib or Mocetinostat in Combination With Nivolumab in Advanced or Metastatic Non-Small Cell Lung Cancer (MRTX-500)

  • Details

ClinicalTrials.gov ID: NCT02954991
Diagnosis Type: NSCLC
USOR Number: 17039

  • Practice Details

11850 Blackfoot St NW, Suite 100
Coon Rapids, Minnesota 55433
571.97 mi. away
P: (763) 712-2100

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Minnesota Oncology - Coon Rapids

TRITON2: A Multicenter, Open-label Phase 2 Study of Rucaparib in Patients with Metastatic Castration-resistant Prostate Cancer Associated with Homologous Recombination Deficiency - CO-338-052

  • Details

ClinicalTrials.gov ID: NCT02952534
Diagnosis Type: NA
USOR Number: 16237

  • Practice Details

11850 Blackfoot St NW, Suite 100
Coon Rapids, Minnesota 55433
571.97 mi. away
P: (763) 712-2100

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Minnesota Oncology - Coon Rapids

TRITON3: A Multicenter, Randomized, Open-label Phase 3 Study of Rucaparib versus Physician's Choice of Therapy for Patients with Metastatic Castration-resistant Prostate Cancer Associated with Homologous Recombination Deficiency (CO-338-063)

  • Details

ClinicalTrials.gov ID: NCT02975934
Diagnosis Type: NA
USOR Number: 16238

  • Practice Details

11850 Blackfoot St NW, Suite 100
Coon Rapids, Minnesota 55433
571.97 mi. away
P: (763) 712-2100

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Coon Rapids

CA209-817: A Phase IIIb/IV Safety and Efficacy Trial of Flat Dose Nivolumab in Combination with Ipilimumab in Participants with Non-Small Cell Lung Cancer

  • Details

ClinicalTrials.gov ID: NCT02869789
Diagnosis Type: NSCLC
USOR Number: 16156

  • Practice Details

11850 Blackfoot St NW, Suite 100
Coon Rapids, Minnesota 55433
571.97 mi. away
P: (763) 712-2100

More Details View Practice Page

Pages